Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Qualigen Therapeutics ( (QLGN) ).
Matt Korenberg resigned immediately as the chairman of the audit committee and independent member of Qualigen Therapeutics’ Board on October 3, 2024, with no disagreements cited regarding company operations or policies. Shortly after, on October 8, Braeden Lichti, an experienced entrepreneur with ties to several investment and advisory companies, was appointed as an independent member of the Board. Additionally, Robert Lim was named the new chairperson of the Audit Committee.
Learn more about QLGN stock on TipRanks’ Stock Analysis page.